Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4939464 | 0.93 | DNM1 (0.44) | DNM1CA12CA1CA9GPR84 | |
| SCHEMBL9807850 | 0.91 | DNM1 (0.48) | DNM1CA12CA1CA9GPR84 | |
| SCHEMBL9807814 | 0.91 | DNM1 (0.48) | DNM1CA12CA1CA9GPR84 | |
| SCHEMBL1548798 | 0.90 | ALDH1A1 (0.36) | DNM1CA12CA1CA9ALDH1A1 | |
| SCHEMBL6684414 | 0.89 | SPHK1 (0.38) | DNM1CA12CA1CA9ALDH1A1 | |
| SCHEMBL14830613 | 0.89 | SPHK1 (0.33) | DNM1CA12CA1CA9ALDH1A1 | |
| SCHEMBL28257130 | 0.87 | TSHR (0.33) | LMNA | |
| SCHEMBL465375 | 0.84 | LMNA (0.32) | CA12CA1CA9CA2LMNA | |
| Bromide SCHEMBL15822037 | 0.84 | ALDH1A1 (0.36) | DNM1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL15821797 | 0.84 | ALDH1A1 (0.36) | DNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10113049-B2 | Thermoplastic resin composition | NIPPON NYUKAZAI CO., LTD. (JP) | 2018-10-30 | — | — | US | claimed |
| US-20150329698-A1 | THERMOPLASTIC RESIN COMPOSITION | NIPPON NYUKAZAI CO., LTD. (JP) | 2015-11-19 | — | — | US | claimed |
| US-20080066644-A1 | Alkylmines, alkanolamine compounds, surfactants, a coloring agent and a solvent; combination results in decreased kogation | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-03-20 | — | — | US | claimed |
| EP-1900785-A1 | Ink Composition for Inkjet Recording | Samsung Electronics Co., Ltd. (KR) | 2008-03-19 | — | — | EP | claimed |
| EP-3518874-B1 | METHODS, COMPOSITIONS AND USES RELATING THERETO | INNOSPEC LTD (GB) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023131780-A1 | CORROSION INHIBITOR | INNOSPEC LIMITED (GB) | 2023-07-13 | — | — | WO | disclosed |
| US-11311471-B2 | Methods, compositions and uses relating thereto | INNOSPEC LIMITED (GB) | 2022-04-26 | — | — | US | disclosed |
| US-11253453-B2 | Reducing colour loss from a dyed material by using an amine salt of a carboxylic acid | INNOSPEC LIMITED (GB) | 2022-02-22 | — | — | US | disclosed |
| US-11234917-B2 | Methods, compositions and uses relating thereto | INNOSPEC LIMITED (GB) | 2022-02-01 | — | — | US | disclosed |
| EP-3518873-B1 | METHODS, COMPOSITIONS AND USES RELATING THERETO | INNOSPEC LTD (GB) | 2022-01-05 | — | — | EP | disclosed |
| CN-106795087-B | Quaternary ammonium compounds and their use as fuel or lubricant additives | 因诺斯佩克有限公司 | 2020-07-14 | — | — | CN | disclosed |
| US-10626341-B2 | Quaternary ammonium compounds as fuel or lubricant additives | INNOSPEC LIMITED (GB) | 2020-04-21 | — | — | US | disclosed |
| EP-1090967-A2 | Composition for film formation, method of film formation, and insulating film | JSR Corporation (JP) | 2001-04-11 | — | — | EP | disclosed |
| EP-1088868-A2 | Composition for film formation, method of film formation, and insulating film | JSR Corporation (JP) | 2001-04-04 | — | — | EP | disclosed |
| EP-0583377-B1 | ONE PACKAGE POLYURETHANE/THERMOPLAST PLASTISOL COMPOSITION | HENKEL TEROSON GMBH (DE) | 1998-10-07 | — | — | EP | disclosed |
| EP-0583377-A1 | ONE PACKAGE POLYURETHANE/THERMOPLAST PLASTISOL COMPOSITION | Henkel Teroson GmbH (DE) | 1994-02-23 | — | — | EP | disclosed |
| US-5284918-A | Blocked isocyanate prepolymer and a cycloaliphatic curing agent | W. R. GRACE & CO.-CONN. (US) | 1994-02-08 | — | — | US | disclosed |
| WO-1992019662-A1 | ONE PACKAGE POLYURETHANE/THERMOPLAST PLASTISOL COMPOSITION | W.R. GRACE & CO.-CONN. (US) | 1992-11-12 | — | — | WO | disclosed |
| EP-0261515-A1 | Storage stable, low temperature, solventless, curable urethane composition | W.R. Grace & Co.-Conn. (US) | 1988-03-30 | — | — | EP | disclosed |
| US-4722969-A | Storage stable, low temperature, solventless, curable urethane composition | W. R. GRACE & CO. (US) | 1988-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11311471-B2 | Methods, compositions and uses relating thereto | LPO, AOC1, HAO2 | DNM1 1635/4885CA12 37/4885CA1 8/4885 |
| US-10626341-B2 | Quaternary ammonium compounds as fuel or lubricant additives | DNMT3A, FANCD2, POLD1 | DNM1 817/4885CA12 1488/4885CA1 654/4885 |
| US-11234917-B2 | Methods, compositions and uses relating thereto | LPO, CA7, AOX1 | DNM1 2259/4885CA12 36/4885CA1 23/4885 |
| US-11253453-B2 | Reducing colour loss from a dyed material by using an amine salt of a carboxylic acid | CA9, CA12, CA7 | DNM1 2929/4885CA12 2/4885CA1 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.